The relationship between insulin resistance and cardiovascular risk factors in overweight/obese non-diabetic Asian adults: The 1992 Singapore National Health Survey

International Journal of Obesity

Volumn 26, Issue 11, 2002, Pages 1511-1516

  Lim, Su Chi ^a,c   Tan, B Y ^b   Chew, S K ^b   Tan, C E ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b MINISTRY OF HEALTH   (Singapore)

^c ALEXANDRA HOSPITAL   (Singapore)

Author keywords

Cardiovascular risk factors; Insulin resistance; Obesity

Indexed keywords

APOLIPOPROTEIN B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ASIAN; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ETHNOLOGY; FEMALE; GLUCOSE INTOLERANCE; HEALTH SURVEY; HOMEOSTASIS; HUMAN; HYPERTENSION; HYPERURICEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SEX DIFFERENCE; SINGAPORE; URIC ACID BLOOD LEVEL;

ADULT; AGED; ASIA; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; HEALTH SURVEYS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; SINGAPORE;

EID: 0036866644     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802140     Document Type: Article

References (29)

1. Krauss RM, Winston M, Fletcher RN, Grundy SM. Obesity: Impact of cardiovascular disease. Circulation 1998; 98: 1472-1476.
2. DeFronzo RA. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Neth J Med 1997; 50: 191-197.
3. Mykkanen L, Haffner SM, Ronnemaa T, Bergman RN, Laakso M. Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors. Am J Epidemiol 1997; 146: 315-321.
4. Haffner SM, D'Agostino R Jr, Mykkänen L, Tracy R, Howard B, Rewers M, Selby J, Savage PJ, Saad MF. Insulin sensitivity in subjects with type 2 Diabetes. Relationship to cardiovascular risk factors: The Insulin Resistance Atherosclerosis Study. Diabetes Care 1999; 22: 562-568.
5. Mather KJ, Kwan F, Corenblum B. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil Steril 2000; 73: 150-156.
6. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of athersclerotic progression. Circulation 1993; 87(Suppl II): II-56-II-65.
7. Suzuki M, Shinozaki K, Kanazawa A, Hara Y, Hattori Y, Tsushima M, Harano Y. Insulin resistance as an independent risk factor for carotid wall thinkening. Hypertension 1996; 28: 593-598.
8. Pergola GD, Ciccone M, Pannacciulli N, Modugno M, Sciaraffia M, Minenna A, Rizzon P, Giorgino R. Lower insulin sensitivity as an independent risk factor for carotid wall thickening in normotensive, non-diabetic, non-smoking normal weight and obese premenopausal women. Int J Obes Relat Metab Disord 2000; 24: 825-829.
9. Tan CE, Emmanuel SC, Tan BY, Jacob E. Prevalence of diabetes and ethnic differences in cardiovascular risk factors. Diabetes Care 1999; 22: 241-247.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
11. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetes Med 1998; 15: 539-553.
12. Campbell P, Gerich J. Impact of obesity on insulin action in volunteer with normal glucose tolerance: Demonstration of a threshold for the adverse effect of obesity. J Clin Endocrinol Metab 1990; 70: 1114-1118.
13. Cefalu WT, Werbel S, Bell-Farrow AD, Terry JG, Wang ZQ, Opara EC et al. Insulin resistance and fat patterning with aging: Relationship to metabolic risk factors for cardiovascular disease. Metabolism 1998; 47: 401-408.
14. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025 Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
15. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy S. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian Men. J Clin Endocrinol Metab 1999; 84: 2329-2335.
16. Deurenberg-Yap M, Chew SK, Lin VFP, Tan BY, van Staveren WA, Deurenberg P. Relationships between indices of obesity and its comorbidities in multi-ethnic Singapore. Int J Obes Relat Metab Disord 2001; 25: 1554-1562.
17. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990; 39: 167-174.
18. Bonora E, Zavaroni I, Apli O et al. Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects. Diabetologia, 1987; 30: 719-723.
19. Bonora E, Moghetti P, Zenere M et al. Beta cell secretion and insulin sensitivity in hypertensive and normotensive obese subjects. Int J Obes 1990; 14: 735-742.
20. Wuorinen-Markkola H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1993; 78: 25-29.
21. Paivi Kekalainen, Helena Sarlund, Markku Iaakso. Long-term association of cardiovascular risk factors with impaired insulin secretion and insulin resistance. Metabolism 2000; 49: 1247-1254.
22. Clausen JO, Borch-Johnsen K, Ibsen H, Pedersen O. Analysis of the relationship between fasting serum uric acid and the insulin sensitivity index in a population-based sample of 380 young healthy Caucasians. Eur J Endocrinol 1998; 138: 63-69.
23. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med 1999; 131: 7-13.
24. Abbott WGH, Lillioja S, Young AA et al. Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes 1987; 36: 897-904.
25. Lillioja S, Mott DM, Howard BV et al. Imparied glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. New Engl J Med 1988; 318: 1217-1225.
26. Ambrosch A, Muhlen I, Kopf D et al. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects. Diabetes Care 1998; 21: 2077-2084.
27. Tan CE. The Relationship between Insulin Resistance and the Atherogenic Lipoprotein Phenotype. Doctoral Thesis, University of Glasgow, July 1996.
28. Hu FB, van Dam RM, Liu S. Diet and risk of type II diabetes: The role of types of fat and carbohydrate. Diabetologia 2001; 44: 805-817.
29. Kissebah AH. Central obesity: Measurement and metabolic effects. Diabetes Rev 1997; 5: 8-20.